4-Bromo-5-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiazole

Catalog No. :
ACSCUS451
CAS No. :
2223032-07-1
Molecular Formula :
C15H17BBrNO2S
Molecular Weight :
366.09

IUPAC Name:4-bromo-5-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiazole

4-Bromo-5-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-5-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiazole
IUPAC Name4-bromo-5-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiazole
Molecular FormulaC15H17BBrNO2S
Molecular Weight366.09
SMILESCC1(C)C(C)(C)OB(C2=CC(C3=C(Br)N=CS3)=CC=C2)O1
InChI KeyKVKCXNYHYLILFN-UHFFFAOYSA-N
Synonym3-(4-Bromothiazol-5-yl)phenylboronic acid pinacol ester;Thiazole, 4-bromo-5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CAS No.2223032-07-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSCUS451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUIDJ176 route compound structure diagram
    ACUIDJ176594823-67-3 In Stock
  4. Then
  5. ACSCUS451 route product structure diagram
    ACSCUS4512223032-07-1
Inquiry

2. ACSCUS451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOJTV349 route compound structure diagram
    ACOJTV349196212-27-8 In Stock
  4. Then
  5. ACSCUS451 route product structure diagram
    ACSCUS4512223032-07-1
Inquiry

Comments (0)